| |
| Glucagon-Like Peptide (GLP) II, human |
|
|

| Cat. No. |
Size |
Price |
Figures |
RP10769-0.5 mg
| 0.5 mg | $ 90.25 | MSDS: 20080715043759 (PDF)
References:
- Chance WT, et al. The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia. Peptides. Apr 2006; 27(4): 883-892.
- Sams A, et al. Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines.
Eur. J. Pharmacol. Feb 2006; 532(1-2): 18-23.
- Stephens J, et al. Glucagon-like peptide-2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets. Am. J. Physiol. Regul. Integr. Comp. Physiol. Feb 2006; 290(2): R283-R289.
|
|---|
| Full Name | | Glucagon-Like Peptide (GLP) II, human |
|
| Alias |
Glucagon-Like PeptideII; Glucagon-Like Peptide 2; Glucagon-Like Peptide2; GLP II; GLPII; GLP 2; GLP2 |
Sequence (one-letter code) |
HADGSFSDEMNTILDNLAARDFINWLIQTKITD | Sequence (three-letter code) | {HIS}{ALA}{ASP}{GLY}{SER}{PHE}{SER}{ASP}{GLU}{MET} {ASN}{THR}{ILE}{LEU}{ASP}{ASN}{LEU}{ALA}{ALA}{ARG} {ASP}{PHE}{ILE}{ASN}{TRP}{LEU}{ILE}{GLN}{THR}{LYS} {ILE}{THR}{ASP} | | Description | Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a potential therapeutic agent for the human subjects with a broad variety of intestinal diseases characterized by intestinal damage and insufficiency. |
|---|
| Formula | C165H254N44O55S1 | | M.W. | 3766.2 | | Cas | 223460-79-5 |
|---|
| Purity | > 95% | | Storage | Store the peptide at -20°C. Keep container tightly closed. |
| * For Non-Clinical Research Use Only *If you cannot find your peptides on our list, try our Express PeptideTM Service, and receive high-quality peptides in eight business days, guaranteed. Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
|
|